[[(3-Hydroxy-2-pyridinyl)amino]methylidene]bisphosphonic acid tetraethyl ester | 144677-06-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机膦酸及其衍生物
• 英文名称: [[(3-Hydroxy-2-pyridinyl)amino]methylidene]bisphosphonic acid tetraethyl ester
• 英文别名: Tetraethyl [(3-hydroxy-2-pyridyl)amino]methandiphosphonate；2-[bis(diethoxyphosphoryl)methylamino]pyridin-3-ol
• CAS: 144677-06-5
• 化学式: C₁₄H₂₆N₂O₇P₂
• 分子量: 396.317
• InChiKey: HQWJNWAHFHTGIO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  25
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  116
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES
  申请人：LEIRAS OY

  公开号：EP0563107B1

  公开（公告）日：2000-05-03
• PYRIDYLBISPHOSPHONATES FOR USE AS A THERAPEUTICAL AGENT
  申请人：LEIRAS OY

  公开号：EP0762883A1

  公开（公告）日：1997-03-19
• BISPHOSPHONIC COMPOUNDS FOR STRENGTHENING OF CORTICAL BONE
  申请人：Schering Aktiengesellschaft

  公开号：EP1328277B1

  公开（公告）日：2007-02-14
• METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, AND ITS USE
  申请人：Schering Oy

  公开号：EP1328277A1

  公开（公告）日：2003-07-23
• Method for the preparation of a pharmaceutical composition, and its use
  申请人：——

  公开号：US20040014726A1

  公开（公告）日：2004-01-22

  The present invention is directed to a method for the preparation of a pharmaceutical composition having osteoclast formation inhibiting or suppressing activity, characterized in that, as the active agent, a compound of the formula (I) is used, in which formula Q 1 is hydrogen, hydroxyl, halogen, amino —NH2, or —OR′, wherein R′ is C1-C4-alkyl or acyl, Q 2 is straight or branched alkyl, hydroxyalkyl or aminoalkyl, or a corresponding unsaturated group optionally substituted at the hydroxy or amino group, or a unsubstituted or substituted, saturated or unsaturated cycloalkyl, which can be bound to the methylene carbon over a straight or branched alkylene group, or is the group (a) wherein Y is a saturated or unsaturated heterocyclic group, or a carbocyclic aromatic group, X is a bond, O, S or NR 3 , wherein R 3 is hydrogen or a protecting group, especially lower alkyl, acyl, aryl or arylalkyl, and n is an integer 0 to 6, R 1 and R 2 are independently hydrogen or C1-C4-alkyl, or it is halogen, and the groups R1 to R4 are the same or different, and mean an alkyl group with 1-5 carbon atoms, whereby one or two of the groups R1 to R4 can also mean hydrogen, or a pharmacologically acceptable salt thereof. 1